Thomas Mandrup-Poulsen
Thomas Mandrup-Poulsen
Professor of Immuno-endocrinology, University of Copenhagen
Verified email at sund.ku.dk - Homepage
TitleCited byYear
Interleukin-1–receptor antagonist in type 2 diabetes mellitus
CM Larsen, M Faulenbach, A Vaag, A Vølund, JA Ehses, B Seifert, ...
New England Journal of Medicine 356 (15), 1517-1526, 2007
15922007
A choice of death–the signal-transduction of immune-mediated beta-cell apoptosis
DL Eizirik, T Mandrup-Poulsen
Diabetologia 44 (12), 2115-2133, 2001
9702001
The role of interleukin-1 in the pathogenesis of IDDM
T Mandrup-Poulsen
Diabetologia 39 (9), 1005-1029, 1996
6611996
Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans
K Bendtzen, T Mandrup-Poulsen, J Nerup, JH Nielsen, CA Dinarello, ...
Science 232 (4757), 1545-1547, 1986
6271986
Interleukin-6 and diabetes: the good, the bad, or the indifferent?
OP Kristiansen, T Mandrup-Poulsen
Diabetes 54 (suppl 2), S114-S124, 2005
5482005
Inflammatory mediators and islet β-cell failure: a link between type 1 and type 2 diabetes
MY Donath, J Størling, K Maedler, T Mandrup-Poulsen
Journal of molecular medicine 81 (8), 455-470, 2003
5242003
Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in …
AK Cardozo, F Ortis, J Storling, YM Feng, J Rasschaert, M Tonnesen, ...
Diabetes 54 (2), 452-461, 2005
4912005
An immune origin of type 2 diabetes?
H Kolb, T Mandrup-Poulsen
Diabetologia 48 (6), 1038-1050, 2005
4722005
Relation between breast-feeding and incidence rates of insulin-dependent diabetes mellitus: a hypothesis
K Borch-Johnsen, T Mandrup-Poulsen, B Zachau-Christiansen, G Joner, ...
The Lancet 324 (8411), 1083-1086, 1984
4461984
Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans
T Mandrup-Poulsen, K Bendtzen, J Nerup, CA Dinarello, M Svenson, ...
Diabetologia 29 (1), 63-67, 1986
4111986
Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes.
S Baekkeskov, M Landin, JK Kristensen, S Srikanta, GJ Bruining, ...
The Journal of clinical investigation 79 (3), 926-934, 1987
3981987
Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity.
T Mandrup-Poulsen, K Bendtzen, CA Dinarello, J Nerup
The Journal of Immunology 139 (12), 4077-4082, 1987
3741987
Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes
CM Larsen, M Faulenbach, A Vaag, JA Ehses, MY Donath, ...
Diabetes care 32 (9), 1663-1668, 2009
3632009
The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation
H Kolb, T Mandrup-Poulsen
Diabetologia 53 (1), 10-20, 2010
3072010
Role of IL-1β in type 2 diabetes
CA Dinarello, MY Donath, T Mandrup-Poulsen
Current Opinion in Endocrinology, Diabetes and Obesity 17 (4), 314-321, 2010
2992010
Poor pregnancy outcome in women with type 2 diabetes
TD Clausen, E Mathiesen, P Ekbom, E Hellmuth, T Mandrup-Poulsen, ...
Diabetes care 28 (2), 323-328, 2005
2932005
Mechanisms of pancreatic beta-cell destruction in type I diabetes.
J Nerup, T Mandrup-Poulsen, J Mølvig, S Helqvist, L Wogensen, ...
Diabetes care 11, 16-23, 1988
2741988
beta-cell apoptosis: stimuli and signaling.
T Mandrup-Poulsen
Diabetes 50 (suppl 1), S58, 2001
2632001
Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes
C Cavelti-Weder, A Babians-Brunner, C Keller, MA Stahel, M Kurz-Levin, ...
Diabetes care 35 (8), 1654-1662, 2012
2532012
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
A Moran, B Bundy, DJ Becker, LA DiMeglio, SE Gitelman, R Goland, ...
The Lancet 381 (9881), 1905-1915, 2013
2422013
The system can't perform the operation now. Try again later.
Articles 1–20